Ceapro Inc. Announces Receipt of Site License from Health Canada
EDMONTON, Alberta -- Ceapro Inc. (TSX-V: CZO), a growth-stage biotechnology company focused on the development and commercialization of active ingredients for healthcare and cosmetic industries, today announced that both of its two Alberta-based bioprocessing plants, located in Leduc and Edmonton, have received a Site License from the Health Canada Natural and Non-Prescription Health Products Directorate. This license enables the Company to fabricate, package, label, release and distribute final products.